Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids and Pain: Sites and Mechanisms of Action
Katarzyna Starowicz, David P. Finn
Advances in pharmacology (2017), pp. 437-475
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history
Sara Anna Bonini, Marika Premoli, Simone Tambaro, et al.
Journal of Ethnopharmacology (2018) Vol. 227, pp. 300-315
Closed Access | Times Cited: 569
Cannabinoids and Pain: New Insights From Old Molecules
Sonja Vučković, Dragana Srebro, Katarina Savić Vujović, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 298
Chronic Pain: Structural and Functional Changes in Brain Structures and Associated Negative Affective States
Seoyon Yang, Min Cheol Chang
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3130-3130
Open Access | Times Cited: 272
European Pain Federation (EFIC) position paper on appropriate use of cannabis‐based medicines and medical cannabis for chronic pain management
Winfried Häuser, David P. Finn, Eija Kalso, et al.
European Journal of Pain (2018) Vol. 22, Iss. 9, pp. 1547-1564
Open Access | Times Cited: 177
Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials
Emma Fisher, Andrew Moore, Alexandra E. Fogarty, et al.
Pain (2020) Vol. 162, Iss. 1, pp. S45-S66
Open Access | Times Cited: 168
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
David P. Finn, Simon Haroutounian, Andrea G. Hohmann, et al.
Pain (2021) Vol. 162, Iss. 1, pp. S5-S25
Open Access | Times Cited: 162
Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain
Nadia Soliman, Simon Haroutounian, Andrea G. Hohmann, et al.
Pain (2021) Vol. 162, Iss. 1, pp. S26-S44
Open Access | Times Cited: 114
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
Pathophysiology of musculoskeletal pain: a narrative review
Filomena Puntillo, Mariateresa Giglio, Antonella Paladini, et al.
Therapeutic Advances in Musculoskeletal Disease (2021) Vol. 13
Open Access | Times Cited: 79
The role of cannabinoids in pain modulation in companion animals
Agatha Miranda-Cortés, Daniel Mota‐Rojas, Nadia Crosignani, et al.
Frontiers in Veterinary Science (2023) Vol. 9
Open Access | Times Cited: 23
Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain
Stevie C. Britch, Alan G. Goodman, Jenny L. Wiley, et al.
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 373, Iss. 3, pp. 416-428
Open Access | Times Cited: 60
Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease
Glauce Crivelaro Nascimento, Daniele Ferrari, Francisco Silveira Guimarães, et al.
Neuropharmacology (2019) Vol. 163, pp. 107808-107808
Closed Access | Times Cited: 58
Pancreas Cancer-Associated Pain Management
Andrew L. Coveler, Jonathan D. Mizrahi, Bory Eastman, et al.
The Oncologist (2021) Vol. 26, Iss. 6, pp. e971-e982
Open Access | Times Cited: 51
Cannabis and pain: a scoping review
Camila Pantoja‐Ruiz, Paula Restrepo-Jiménez, Camilo Castañeda‐Cardona, et al.
Brazilian Journal of Anesthesiology (English Edition) (2021) Vol. 72, Iss. 1, pp. 142-151
Open Access | Times Cited: 49
Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
Raquel Maria Pereira Campos, Andrey F. L. Aguiar, Yolanda Paes-Colli, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 44
Mechanisms of bone pain: Progress in research from bench to bedside
Gehua Zhen, Yuhan Fu, Chi Zhang, et al.
Bone Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 36
Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research
Stephanie Bourke, Anne Katrin Schlag, Saoirse E. O’Sullivan, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108216-108216
Open Access | Times Cited: 28
Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks
Samuel P Ang, Shawn Sidharthan, Wilson C. Lai, et al.
Pain and Therapy (2023) Vol. 12, Iss. 2, pp. 355-375
Open Access | Times Cited: 17
Modulation of pulmonary immune function by inhaled cannabis products and consequences for lung disease
Matthew Preteroti, Emily T. Wilson, David H. Eidelman, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 17
Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases
K. J. CROWLEY, Łukasz Kiraga, Edyta Miszczuk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6682-6682
Open Access | Times Cited: 6
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
Yara Mouhamed, Andrey E. Vishnyakov, Bessi Qorri, et al.
Drug Healthcare and Patient Safety (2018) Vol. Volume 10, pp. 45-66
Open Access | Times Cited: 51
Adenosine receptors: Emerging non-opioids targets for pain medications
Soo‐Min Jung, Lee Peyton, Hesham Essa, et al.
Neurobiology of Pain (2022) Vol. 11, pp. 100087-100087
Open Access | Times Cited: 24
Glutamatergic systems in neuropathic pain and emerging non-opioid therapies
Rhea Temmermand, James E. Barrett, Andréia C. K. Fontana
Pharmacological Research (2022) Vol. 185, pp. 106492-106492
Open Access | Times Cited: 22
Cannabinoids for Acute Pain Management: Approaches and Rationale
Mihai Botea, Lukas Andereggen, Richard D. Urman, et al.
Current Pain and Headache Reports (2024) Vol. 28, Iss. 7, pp. 681-689
Open Access | Times Cited: 5
The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders
Anna Stasiłowicz-Krzemień, Wiktoria Nogalska, Zofia Maszewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5749-5749
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top